Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine-Reference-Cited by-同舟云学术

Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine

Published:2022-04-20 Issue:1 Volume:43 Page:1057-1071
ISSN:0889-7077
Container-title:Substance Abuse
language:en
Short-container-title:Substance Abuse

Author:

Landis Rachel K.¹²^ORCID,Levin Jonathan S.²,Saloner Brendan³,Gordon Adam J.⁴⁵⁶^ORCID,Dick Andrew W.⁷,Sherry Tisamarie B.²,Leslie Douglas L.⁸,Sorbero Mark⁹,Stein Bradley D.⁹¹⁰^ORCID

Affiliation:

1. George Washington University Trachtenberg School of Public Policy and Public Administration, Washington, District of Columbia, USA

2. RAND Corporation, Arlington, Virginia, USA

3. Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

4. Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Salt Lake City, Utah, USA

5. Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA

6. Informatics, Decision-Enhancement, and Analytic Sciences Center (IDEAS), Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA

7. RAND Corporation, Boston, Massachusetts, USA

8. Department of Public Health Sciences and Center for Applied Studies in Health Economics, Penn State College of Medicine, Hershey, Pennsylvania, USA

9. RAND Corporation, Pittsburgh, Pennsylvania, USA

10. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

Funder

National Institute on Drug Abuse

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/08897077.2022.2060424

Reference93 articles.

1. The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

2. The cost of opioid use disorder and the value of aversion

3. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study

4. Kaiser Family Foundation. Opioid overdose deaths and opioid overdose deaths as a percent of all drug overdose deaths. 2018. https://www.kff.org/other/state-indicator/opioid-overdose-deaths/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type;Addiction;2024-09-07

2. Age and racial and ethnic disparities in filled buprenorphine prescriptions post‐emergency department visit in Nevada;Journal of the American College of Emergency Physicians Open;2024-09-06

3. Composition of buprenorphine prescribing networks in Medicaid and association with quality of care;Journal of Substance Use and Addiction Treatment;2024-08

4. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit;Frontiers in Public Health;2024-06-18

5. Impact of Perceived Access and Treatment Knowledge on Medication Preferences for Opioid Use Disorder;Substance Use & Addiction Journal;2024-06-03